文献速递重症综合管理与镇静镇痛呼吸衰竭与机械通气

临床肺部感染评分对重症监护病房细菌性重症肺炎患者抗生素使用时长及限定日剂量的影响

[Performance of clinical pulmonary infection score induces the duration and defined daily doses of antibiotics in patients with bacterial severe pneumonia in intensive care unit].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2019-01-01
一句话结论在ICU细菌性重症肺炎患者中,以临床肺部感染评分(CPIS)指导抗生素使用可缩短抗生素使用时长并降低限定日剂量(DDDs),且不增加ICU死亡率。

该研究纳入贵州医科大学附属医院ICU重症呼吸与感染病房2016年11月至2017年10月的重症肺炎患者,CPIS指导组(2017年5月至10月,65例)根据CPIS评分启动和停用抗生素,对照组(2016年11月至2017年4月,101例)由主任医师临床经验决定抗生素使用。两组基线资料可比,机械通气时长、ICU住院天数、ICU死亡率及28天、90天、12个月累积生存率均无显著差异。CPIS指导组抗生素使用时长(7.54±4.81天 vs 9.88±4.96天,P<0.01)和DDDs(17.58±13.09 vs 22.73±18.31,P<0.05)均低于对照组。作者认为CPIS对指导ICU重症肺炎患者抗生素使用具有价值。

要点

  • CPIS指导组抗生素使用时长7.54±4.81天,短于经验治疗对照组的9.88±4.96天(P<0.01)。
  • CPIS指导组抗生素DDDs为17.58±13.09,低于对照组的22.73±18.31(P<0.05)。
  • 两组机械通气时长、ICU住院天数、ICU死亡率及28天、90天、12个月累积生存率均无显著差异(均P>0.05)。
  • CPIS指导方案:首次CPIS评分>5分启动抗菌治疗,每2-3天动态评估;评分<5分时2天后复评,仍<5分则停用抗菌药物。
  • 对照组抗生素使用完全由主任医师临床经验决定。

适用人群与场景

  • 贵州医科大学附属医院ICU重症呼吸与感染病房收治的细菌性重症肺炎患者,CPIS组为2017年5月至10月收治的65例,对照组为2016年11月至2017年4月收治的101例。

诊断标准与关键阈值

  • 临床肺部感染评分(CPIS):首次CPIS评分>5分给予抗菌治疗;治疗过程中每2-3天动态评估,CPIS评分<5分时2天后复评,仍<5分则停用抗菌药物。

处置流程与药物剂量

  • CPIS指导组:首次CPIS评分>5分启动抗菌治疗,每2-3天动态评估CPIS评分;评分<5分时2天后再次评估,仍<5分则停用抗菌药物。
  • 对照组:抗生素使用完全由主任医师临床经验决定。

研究设计与关键结果

  • 研究类型为前后对照的临床研究,纳入贵州医科大学附属医院ICU重症呼吸与感染病房两个阶段收治的细菌性重症肺炎患者,CPIS指导组65例,经验治疗对照组101例。
  • 两组性别构成、年龄、基础疾病、生命体征、急性生理学与慢性健康状况评分Ⅱ(APACHEⅡ)及入院时外周血常规均无显著差异,基线可比。
  • CPIS指导组抗生素使用时长7.54±4.81天,短于对照组的9.88±4.96天(P<0.01)。
  • CPIS指导组抗生素DDDs为17.58±13.09,低于对照组的22.73±18.31(P<0.05)。
  • 两组机械通气时长[小时:126.0(69.0,228.8)vs 120.0(72.0,192.0)]、ICU住院天数[天:7.0(5.0,11.0)vs 8.0(5.0,14.0)]及ICU死亡率[18.8%(19/101)vs 26.2%(17/65)]均无显著差异(均P>0.05)。
  • Kaplan-Meier生存曲线分析显示两组28天(log-rank检验:χ2=0.540,P=0.462)、90天(χ2=0.332,P=0.564)及12个月(χ2=0.833,P=0.362)累积生存率均无显著差异。

证据类型、等级与局限

  • 证据类型:单中心前后对照临床研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为CPIS指导的治疗方案可缩短ICU重症肺炎患者抗生素使用时长并降低抗生素DDDs,提示CPIS在指导此类患者抗生素使用方面具有价值。
  • 该方案未增加机械通气时长、ICU住院天数、ICU死亡率及28天、90天、12个月累积生存率方面的不良影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To explore the impacts of clinical pulmonary infection score (CPIS) on duration and defined daily doses (DDDs) of antibiotics in patients with bacterial severe pneumonia in intensive care unit (ICU).

METHODS: Patients with severe pneumonia, whose antibiotic usage was prescribed with the guide of CPIS, and admitted to ICU severe respiratory and infectious disease ward of Guizhou Medical University Affiliated Hospital from May 2017 to October 2017 were enrolled as CPIS group. Patients with the first CPIS score > 5 were given antimicrobial therapy, and the score was dynamically evaluated every 2-3 days. If the CPIS score < 5, the score was evaluated again after 2 days. If the score was still < 5, the antimicrobial drugs were discontinued. Patients admitted to the same ward from November 2016 to April 2017 were regarded as controls, of whom the antibiotic usage was completely conducted by the clinical experience of the chief physician. The duration and DDDs of antibiotics were compared between patients in two groups. At the same time, the usage of ventilator and prognostic indicators (the length of ICU stay, ICU mortality) were recorded. Kaplan-Meier survival curve was drawn, and the cumulative survival rates of 28 days, 90 days and 12 months were analyzed and compared between the two groups.

RESULTS: In our department, 177 and 182 patients were admitted to ICU from November 2016 to April 2017 and from May 2017 to October 2017, respectively, of whom 101 and 65 patients with severe pneumonia were collected respectively during the two stages. There was no significant difference in gender composition, age, underlying diseases, vital signs, acute physiology and chronic health evaluation II (APACHE II) score, or peripheral blood routine at admission between the two groups, indicating that the baseline data of the two groups were equally comparable. During the treatment process, there was no significant difference in the duration of mechanical ventilation [hours: 126.0 (69.0, 228.8) vs. 120.0 (72.0, 192.0)], the length of ICU stay [days: 7.0 (5.0, 11.0) vs. 8.0 (5.0, 14.0)], or ICU mortality [18.8% (19/101) vs. 26.2% (17/65)] between the control group and CPIS group (all P > 0.05). Kaplan-Meier survival curve analysis showed that there was no significant difference in the cumulative survival rate of 28 days (log-rank test: χ2 = 0.540, P = 0.462), 90 days (log-rank test: χ2 = 0.332, P = 0.564) or 12 months (log-rank test: χ2 = 0.833, P = 0.362). Patients from CPIS guided group, however, had a shorter duration of antibiotics usage (days: 7.54±4.81 vs. 9.88±4.96, P < 0.01), and had a lower DDDs of antibiotics (17.58±13.09 vs. 22.73±18.31, P < 0.05) as compared with those in the control group.

CONCLUSIONS: CPIS-guided therapeutic regimen shortens antibiotic duration and decreases antibiotic DDDs in patients with severe pneumonia in ICU, indicating the values of CPIS in guiding antibiotics usage in these patients.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Shen F, Wu Y, Wang Y, et al. [Performance of clinical pulmonary infection score induces the duration and defined daily doses of antibiotics in patients with bacterial severe pneumonia in intensive care unit]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2019. PMID: 31198139. doi:10.3760/cma.j.issn.2095-4352.2019.05.007

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。